The patient, now 40 years old, presented in 1973 with mesangiocapillary glomerulonephritis (hypocomplimentaemic with C3 nephritic factor) and subsequently developed progressive renal failure. In 1978 classical neuralgic amyotrophy (brachial neuritis) occurred in both arms and remitted over the next three months, his sister having had similar episodes some years before. Four months later he underwent a successful cadaver renal transplant. Subsequently the patient had several episodes of rejection and suffered from recurrent chest infections during the first year. One year after transplantation he developed avascular necrosis of the left femoral head (presumed to be due to steroids) and the hip was fractured in 1982 after a fall. He returned to work between these episodes and remains fairly active, using a walking stick.
In 1985 he presented with left lower lobe pneumonia after an influenza A infection and he was referred for respiratory assessment. Review of his chest radiographs showed progressively rising diaphragms bilaterally over the previous seven years, starting immediately after the renal transplant; a few linear basal shadows were apparent in the later films. Specific questioning disclosed a history of at least five years' increasing shortness of breath on exertion, substantial orthopnoea, and sleep disturbance. He had been taking azathioprine 175 mg, prednisolone 10 mg, bendrofluazide 5 mg, atenolol 200 mg, and prazosin 6 mg daily since the transplantation.
Examination in the supine posture showed obvious abdominal paradox with inspiration. There was no detectable weakness in any other muscles, although for some time before the renal transplant there had been generalised weakness, presumed to be due to chronic uraemia, and some specific weakness due to the neuralgic amyotrophy. His vital capacity in the upright posture was 3 4 1 (60% predicted normal), falling to 12 1 supine (65% fall). Arterial The apnoea rate during REM sleep was about 55 an hour. The transcutaneous Pco, (Hewlett-Packard 47210A) rose from 7-3 kPa (55 mm Hg) awake and semirecumbent (equivalent to a measured arterial value of 5 4 kPa, 41 mm Hg) to 9 1 kPa (68 mm Hg) by the end of the REM sleep period: an equal rise in arterial Pco, (1 8 kPa, 14 mm Hg) would be predicted from these transcutaneous measurements.' In obese subjects, with very poor inspiratory muscle function, surface measurements may miss small inspiratory efiorts against a collapsed pharynx (that is, obstructive sleep apnoea). This man was not, however, obese, he had a reasonable maximum inspiratory pressure, and the abdominal tracing was flat during the apnoeic periods (in the presence of a paralysed diaphragm the abdominal wall movement is an indirect monitor of oesophageal pressure). In addition, his breathing was always absolutely quiet and there was no evidence of upper airways obstruction at any time.
We are therefore confident that this was not obstructive sleep apnoea. The findings in this patient also show that bilateral diaphragm paralysis may produce substantial hypoventilation and apnoea with hypoxaemia and hypercapnia during REM sleep before the development of hypercapnia and serious hypoxaemia during the day. This further supports the idea that specific REM sleep induced hypoventilation and apnoea may be the factor that initiates eventual respiratory failure in patients with bilateral diaphragm paralysis. Time will tell if this patient goes on to develop daytime hypoxaemia and hypercapnia. 
